Related Experiment Videos
Do angiographic data support a detailed classification of hypertensive fundus changes?
1University Eye Hospital Basel, Switzerland, and University Eye Hospital Aachen, Germany. Mona.Pache@unibas.ch
Journal of Human Hypertension
|May 31, 2002
Summary
Hypertensive retinopathy shows changes in the eye's blood vessels. While fluorescein angiography reveals differences between mild and severe stages, it cannot precisely match the four-stage ophthalmoscopic classification.
Area of Science:
- Ophthalmology
- Cardiology
- Medical Imaging
Background:
- The eye serves as both a target organ and a prognostic indicator for arterial hypertension.
- Ophthalmoscopic classifications grade hypertensive fundus changes into four stages.
- Fluorescein angiography allows assessment of hypertensive alterations in perifoveal microcirculation.
Purpose of the Study:
- To determine if angiographic findings correlate with established ophthalmoscopic classifications of hypertensive retinopathy.
- To compare perifoveal microcirculation in hypertensive patients across different severity stages and with healthy individuals.
Main Methods:
- Compared perifoveal microcirculation in 143 hypertensive patients (stages I-IV) and normal subjects using fluorescein angiography.
- Quantified perifoveal intercapillary area (PIA), foveal avascular zone (FAZ), and capillary blood velocity (CBV) via digital image analysis.
- Utilized Neubauer's classification, a modification of the Keith and Wagener system.
Main Results:
- All hypertensive patients exhibited reduced perifoveal capillary density and decreased capillary blood velocity compared to controls.
- Significant differences in PIA and CBV were observed between mild (stages I-II) and severe (stages III-IV) hypertensive retinopathy.
- No significant angiographic differences were found between stages I and II, nor between stages III and IV.
Conclusions:
- Fluorescein angiography demonstrates significant angiographic differences between mild and severe hypertensive retinopathy.
- A four-stage differentiation, as seen in ophthalmoscopy, is not achievable with current angiographic methods for hypertensive retinopathy.